Refractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody: a case report

This case report describes a female with amyopathic anti-MDA5+ dermatomyositis who underwent emergency double lung transplantation due to rapidly progressive interstitial lung disease. Following transplantation, she developed acute antibody-mediated rejection (AMR). Despite multiple rounds of immunosuppressive therapy, her condition continued to deteriorate, and her donor-specific anti-human leukocyte antigen antibody levels increased markedly. An experimental treatment, imlifidase-an immunoglobulin G endopeptidase-was employed as a rescue therapy. This case highlights the complexity of posttransplant management of AMR and emphasizes the need for dedicated clinical trials to provide additional data.

Authors

Institutions

Publication Details

Journal
Clinical Transplantation and Research
Published
2025-10-01
DOI
https://doi.org/10.4285/ctr.25.0034
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody: a case report

Domitille Mouren, Brice Lortat‐Jacob, Yves Allenbach, Y. Uzunhan et al.
Clinical Transplantation and Research
Inflammatory Myopathies and Dermatomyositis
article

Refractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody: a case report

Domitille Mouren, Brice Lortat‐Jacob, Yves Allenbach, Y. Uzunhan, Cloé Comarmond, Jean‐Luc Taupin, Aurélie Cazes, Cendrine Godet, Vincent Bunel, Jean Alexandre, Mathilde Salpin, Jonathan Messika, G. Weisenburger, Pierre Mordant, Raphaël Borie, Hervé Mal, Antoine Roux, Louise Chantelot
article en

Abstract

This case report describes a female with amyopathic anti-MDA5+ dermatomyositis who underwent emergency double lung transplantation due to rapidly progressive interstitial lung disease. Following transplantation, she developed acute antibody-mediated rejection (AMR). Despite multiple rounds of immunosuppressive therapy, her condition continued to deteriorate, and her donor-specific anti-human leukocyte antigen antibody levels increased markedly. An experimental treatment, imlifidase-an immunoglobulin G endopeptidase-was employed as a rescue therapy. This case highlights the complexity of posttransplant management of AMR and emphasizes the need for dedicated clinical trials to provide additional data.

Clinical Transplantation and ResearchVol. 39(4)
Université Claude Bernard Lyon 1 (FR), Délégation Paris 7 (FR), Université Paris Cité (FR), Sorbonne Université (FR), Université Sorbonne Paris Nord (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Lariboisière (FR), Pitié-Salpêtrière Hospital (FR), Hôpital Avicenne (FR), Hôpital Saint-Louis (FR), Hôpital Bichat-Claude-Bernard (FR), Hôpital Foch (FR)
Openalex Percentile: Top 63%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.